guest ::
| Home > Publications Database > Minor neuropsychological deficits in patients with subjective cognitive decline |
| Home > Publications Database > Minor neuropsychological deficits in patients with subjective cognitive decline |
| Journal Article | DZNE-2021-00066 |
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
2020
Ovid
[S.l.]
This record in other databases: 
Please use a persistent id in citations: doi:10.1212/WNL.0000000000010142
Abstract: Objective: To determine the nature and extent of minor neuropsychological deficits in patients with subjective cognitive decline (SCD) and their association with CSF biomarkers of Alzheimer disease (AD).Method: We analyzed data from n = 449 cognitively normal participants (n = 209 healthy controls, n = 240 patients with SCD) from an interim data release of the German Center for Neurodegenerative Diseases Longitudinal Cognitive Impairment and Dementia Study (DELCODE). An extensive neuropsychological test battery was applied at baseline for which we established a latent, 5 cognitive domain factor structure comprising learning and memory, executive functions, language abilities, working memory, and visuospatial functions. We compared groups in terms of global and domain-specific performance and correlated performance with different CSF markers of AD pathology.Results: We observed worse performance (Cohen d = ≈0.25-0.5, adjusted for age, sex differences with analysis of covariance) in global performance, memory, executive functions, and language abilities for the SCD group compared to healthy controls. In addition, worse performance in these domains was moderately (r = ≈0.3) associated with lower CSF β-amyloid42/40 and CSF β-amyloid42/phosphorylated tau181 in the whole sample and specifically in the SCD subgroup.Conclusions: Within the spectrum of clinically unimpaired (i.e., before mild cognitive impairment) cognitive performance, SCD is associated with minor deficits in memory, executive function, and language abilities. The association of these subtle cognitive deficits with AD CSF biomarkers speaks to their validity and potential use for the early detection of underlying preclinical AD.
Keyword(s): Aged (MeSH) ; Amyloid beta-Peptides: cerebrospinal fluid (MeSH) ; Case-Control Studies (MeSH) ; Cognitive Dysfunction: cerebrospinal fluid (MeSH) ; Cognitive Dysfunction: physiopathology (MeSH) ; Cognitive Dysfunction: psychology (MeSH) ; Diagnostic Self Evaluation (MeSH) ; Executive Function (MeSH) ; Factor Analysis, Statistical (MeSH) ; Female (MeSH) ; Humans (MeSH) ; Language (MeSH) ; Language Tests (MeSH) ; Learning (MeSH) ; Male (MeSH) ; Memory, Short-Term (MeSH) ; Middle Aged (MeSH) ; Neuropsychological Tests (MeSH) ; Peptide Fragments: cerebrospinal fluid (MeSH) ; Phosphorylation (MeSH) ; Spatial Navigation (MeSH) ; tau Proteins: cerebrospinal fluid (MeSH)
; Allianz-Lizenz ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Essential Science Indicators ; IF >= 10 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Dataset
Dataset: Minor neuropsychological deficits in patients with subjective cognitive decline
Dryad (2019) [10.5061/dryad.pg4f4qrjp]
BibTeX |
EndNote:
XML,
Text |
RIS
